UK
UK
Dec-17
Cardiovascular Pharmacoepidemiology
Read moreDec-17
Nov-17
Cardiovascular Pharmacoepidemiology
Read moreOct-17
Cardiovascular Pharmacoepidemiology
Read moreSep-17
Cardiovascular Pharmacoepidemiology
Read moreSep-17
Cardiovascular Healthcare Cost Mental Health
Read moreSep-17
Cardiovascular Pharmacoepidemiology
Read moreSep-17
Aug-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-17
Cardiovascular Pharmacoepidemiology
Read moreAug-17
| Date | Title | Categories | |
|---|---|---|---|
| Dec-17 | Meloxicam and risk of myocardial infarction: a population-based nested case-control study | Read more | |
| Dec-17 | Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK | Read more | |
| Nov-17 | Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project | Read more | |
| Oct-17 | The treatment of paroxysmal atrial fibrillation in UK primary care | Read more | |
| Oct-17 | Use of Bisphosphonate and Risk of Incident Atrial Fibrillation in a Population-Based Study | Read more | |
| Sep-17 | Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVD-REAL study | Read more | |
| Sep-17 | Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE) | Read more | |
| Sep-17 | The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK | Read more | |
| Sep-17 | Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women | Read more | |
| Aug-17 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study | Read more | |
| Aug-17 | Comparative Cardiovascular Safety of Strontium Ranelate and Bisphosphonates Amongst Patients with No Contraindications: a Multidatabase Study in our European Countries by the EU-ADR Alliance | Read more | |
| Aug-17 | Risk of first ischemic cerebrovascular event in a cohort of incident heart failure patients | Read more |
